Showing 221-230 of 2501 results for "".
Establishing Our Foundation of LGMD2I/R9
https://practicalneurology.com/programs/cme/establishing-our-foundation-of-lgmd2ir9/35588/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Recognizing Early Signs of LGMD2I/R9
https://mededonthego.com/programs/cme/recognizing-early-signs-of-lgmd2ir9/35878/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Advancing Care: Clinical Innovations on the Horizon
https://mededonthego.com/programs/cme/advancing-care-clinical-innovations-on-the-horizon/35881/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.The Role of Multidisciplinary Care in LGMD2I/R9
https://mededonthego.com/programs/cme/the-role-of-multidisciplinary-care-in-lgmd2ir9/35880/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Movement Disorders Moment: Comprehensive Care in Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-comprehensive-care-in-movement-disorders/32034/Building a team to address all aspects of movement disorders care is crucial for maximixing patient care and quality of life.Decreasing Progression, Increasing Function
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/decreasing-progression-increasing-function/30706/A small Phase I ALS study is getting big results with stem cell treatment.Dementia Insights: A Specialist Reviews Still Alice
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-a-specialist-reviews-still-alice/30567/In the Pipeline A New Image Search: PET Amyloid Imaging Agent is Yielding Results
https://practicalneurology.com/diseases-diagnoses/imaging-testing/in-the-pipeline-a-new-image-search-pet-amyloid-imaging-agent-is-yielding-results/30699/Piramal Imaging shared promising results from five studies evaluating the company's PET amyloid imaging agent (florbetaben F18*) at the 2013 Alzheimer's Association International Conference this summer.Viewpoints: Annoyances are Unavoidable; Frustration Isn't
https://practicalneurology.com/columns/practice-management/viewpoints-annoyances-are-unavoidable-frustration-isnt/30800/More research should be devoted to what bugs physicians and detracts from the care of our patients.Special Report: Follow-on Biologics
https://practicalneurology.com/columns/practice-management/special-report-follow-on-biologics/30812/